Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Diagnostic kits and methods configured to rapidly and non-invasively determine physiologic levels of galactose-deficient IgA1 (Gd-IgA1) in the subject of IgA nephropathy

Diagnostic kits and methods configured to rapidly and non-invasively determine physiologic levels of galactose-deficient IgA1 (Gd-IgA1) in the subject of IgA nephropathy

US Patent 12000841 · Granted Jun 4, 2024

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for ameliorating progression of renal fibrosis and treating renal fibrosi2025
Method for ameliorating progression of renal fibrosis and treating renal fibrosi2025
Image correction system and method2025
Tris DBA pharmaceutical composition and its use for treating autoimmune diseases2024
Tris DBA pharmaceutical composition and its use for treating autoimmune diseases2024
In vitro immune synapse system and method of in vitro evaluating immune response2023
Perovskite film, precursor composition thereof, method for preparing the same, a2023
Perovskite film and manufacturing method thereof2022
Glycoconjugate vaccines, preparation method and uses thereof2021
Klebsiella pneumoniae capsule polysaccharide vaccines2021
Display panel2020
Use of ginsenoside M1 for inhibiting renal fibrosis2019